Description
Catalogue Number | IM102290 |
CAS No. | 668270-12-0 |
Chemical Name | Linagliptin |
Synonyms | 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; BI 1356; BI 1356BS; ONDERO; |
Molecular Formula | C₂₅H₂₈N₈O₂ |
Molecular Weight | 472.55 |
Appearance | White to Orange Solid |
Melting Point | 187-190ºC |
Storage | 4°C |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Applications | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
Note: All Products are stable to be shipped at room temperature, unless otherwise specified.